Ifp Advisors, Inc Tenaya Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.59 Billion
- Q3 2025
A detailed history of Ifp Advisors, Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 506 shares of TNYA stock, worth $688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
506
Previous 1,309
61.34%
Holding current value
$688
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
97Shares Held
38.1MCall Options Held
313KPut Options Held
61.1K-
Column Group LLC San Francisco, CA9.4MShares$12.8 Million18.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$6.89 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.5MShares$6.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.54 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.68MShares$2.28 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $56.3M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...